|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | NSC-301739 2HCl, Mitozantrone 2HCl | Storage (From the date of receipt) |
3 years -20°C powder 1 years -80°C in solvent |
| 化学式 | C22H29ClN4O6.2HCl |
|||
| 分子量 | 517.4 | CAS No. | 70476-82-3 | |
| Solubility (25°C)* | 体外 | DMSO | 104 mg/mL (201.0 mM) | |
| Water | 104 mg/mL (201.0 mM) | |||
| Ethanol | Insoluble | |||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
||||
| 製品説明 | Mitoxantrone 2HClは、Mitoxantroneの二塩酸塩です。Mitoxantroneは、type II topoisomeraseおよびprotein kinase C (PKC)の阻害剤であり、PKCに対するIC50は8.5 μMです。Mitoxantroneは、MCF-7/wt細胞の増殖をIC50 0.42 μMで阻害します。Mitoxantroneはapoptosisも誘導します。 |
|---|---|
| in vitro | Mitoxantrone induces DNA fragmentation and the proteolytic cleavage of poly(ADP-ribose) polymerase (PARP), a marker of the activation of caspases, in all the patients studied, demonstrating that the cytotoxic effect of mitoxantrone is due to induction of apoptosis. Mitoxantrone activates NFkappaB and stimulates IkappaBalpha degradation in the promyelocytic leukemia cell line HL60 but not in the variant cells, HL60/MX2 cells, which lack the beta isoform of topoisomerase II and express a truncated alpha isoform that results in an altered subcellular distribution. Mitoxantrone inhibits proliferation of activated PBMCs, B lymphocytes, or antigen-specific T-cell lines (TCLs) stimulated on antigen-presenting cells (APCs) in a dose-dependent manner. Mitoxantrone induces apoptosis of PBMCs, monocytes and DCs at low concentrations, whereas higher doses causes cell lysis. |
| in vivo | Mitoxantrone transiently decreases the growth rate of HID xenografts in mice but does not affect that of PAC120 xenografts. Mitoxantrone results in the severity of the cardiac lesions and the nephropathy and the intestinal toxicity in spontaneously hypertensive rats. Mitoxantrone and iron(III) form a strong 2:1 complex, in which mitoxantrone may be acting as a tridentate ligand. |
|

Data from [Data independently produced by , , Cell, 2018, 174(5):1200-1215]

Data from [Data independently produced by , , EBioMedicine, 2017, 15:48-61]

Data from [Data independently produced by , , Electrochimica Acta, 2015, 165:430-442.]
| Identifying Age-Modulating Compounds Using a Novel Computational Framework for Evaluating Transcriptional Age [ Aging Cell, 2025, e70075] | PubMed: 40307992 |
| A functional comparison of two transplantable syngeneic mouse models of melanoma: B16F0 and YUMM1.7 [ Biol Open, 2025, 14(9)bio062175] | PubMed: 40878826 |
| Propafenone facilitates mitochondrial-associated ferroptosis and synergizes with immunotherapy in melanoma [ J Immunother Cancer, 2024, 12(11)e009805] | PubMed: 39581704 |
| Deletion of the mitochondrial calcium uniporter in adipose tissue promotes energy expenditure and alleviates diet-induced obesity [ Mol Metab, 2024, 80:101873] | PubMed: 38199601 |
| Mitoxantrone ameliorates ineffective erythropoiesis in a β-thalassemia intermedia mouse model [ Blood Adv, 2024, 8(15):4017-4024] | PubMed: 38861356 |
| Patient-derived rhabdomyosarcoma cells recapitulate the genetic and transcriptomic landscapes of primary tumors [ iScience, 2024, 27(10):110862] | PubMed: 39319271 |
| Immuno-oncological effects of standard anticancer agents and commonly used concomitant drugs: an in vitro assessment [ BMC Pharmacol Toxicol, 2024, 25(1):25] | PubMed: 38444002 |
| Visualization strategies to aid interpretation of high-dimensional genotoxicity data [ Environ Mol Mutagen, 2024, 10.1002/em.22604] | PubMed: 38757760 |
| Carbonic anhydrase IX inhibitor S4 triggers release of DAMPs related to immunogenic cell death in glioma cells via endoplasmic reticulum stress pathway [ Cell Commun Signal, 2023, 21(1):167] | PubMed: 37386564 |
| Development of Novel Epigenetic Anti-Cancer Therapy Targeting TET Proteins [ Int J Mol Sci, 2023, 10.3390/ijms242216375] | PubMed: 38003566 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。